 GAVIN
|
Gador
|
| pregabalina |
Antiepiléptico |
| 150 mg cáps.x 28 | $46.668,31 | (30/08/24) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $21.586,35 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $27.903,21 AF $18.765,10 |
|
|
|
|
| 150 mg cáps.x 30 | $49.190,04 | (03/12/24) |
| PAMI |
|
| AF $22.118,33 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $27.989,52 AF $21.200,52 |
|
|
|
|
| 25 mg cáps.x 28 | $10.221,16 | (30/08/24) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $4.217,74 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $7.206,03 AF $3.015,13 |
|
|
|
|
| 25 mg cáps.x 30 | $10.550,51 | (03/12/24) |
| PAMI |
|
| AF $4.404,98 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $7.262,08 AF $3.288,43 |
|
|
|
|
| 300 mg cáps.x 28 | $64.223,31 | (16/07/24) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $29.747,12 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $42.426,32 AF $21.796,99 |
|
|
|
|
| 300 mg cáps.x 30 | $64.051,09 | (03/12/24) |
| PAMI |
|
| AF $29.894,51 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $41.488,21 AF $22.562,88 |
|
|
|
|
| 50 mg cáps.x 28 | $20.910,03 | (30/08/24) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $8.518,06 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $16.192,02 AF $4.718,01 |
|
|
|
|
| 50 mg cáps.x 30 | $22.771,41 | (03/12/24) |
| PAMI |
|
| AF $9.818,36 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $15.449,24 AF $7.322,17 |
|
|
|
|
| 75 mg cáps.x 28 | $27.048,93 | (16/07/24) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $13.038,30 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $18.452,49 AF $8.596,44 |
|
|
|
|
| 75 mg cáps.x 30 | $29.224,09 | (03/12/24) |
| PAMI |
|
| AF $13.615,93 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $19.932,47 AF $9.291,62 |
|
|
|
|
| |
